Nemet Marko, Vasilić Milica, Ergelašev Sanja, Kuhajda Ivan, Ergelašev Ivan
Internal Medicine, Faculty of Medicine, University of Novi Sad, Novi Sad, SRB.
Cardiology, Institute for Cardiovascular Diseases of Vojvodina, Sremska Kamenica, SRB.
Cureus. 2022 Aug 1;14(8):e27549. doi: 10.7759/cureus.27549. eCollection 2022 Aug.
Malignant pleural effusion refers to the presence of fluid in the pleural space due to an underlying malignancy. Malignant pleural effusion is sometimes accompanied by the formation of fibrous adhesions resulting in a multiloculated effusion. This diminishes the efficacy of drainage and makes successful pleurodesis impossible, leaving the patients with severe shortness of breath. In the process of freeing the pleural space from fluid-filled loculations, intrapleural application of fibrinolytic is being investigated as a possible therapeutic approach. Here, we report four cases of adult patients hospitalized for malignant pleural effusions who were treated with intrapleural fibrinolytic therapy at the Institute for Pulmonary Diseases of Vojvodina, Republic of Serbia.
恶性胸腔积液是指由于潜在的恶性肿瘤导致胸腔内出现液体。恶性胸腔积液有时会伴有纤维粘连的形成,导致胸腔积液呈多房性。这会降低引流效果,使成功的胸膜固定术无法实现,从而使患者出现严重的呼吸急促。在将胸腔从充满液体的分隔中解放出来的过程中,胸膜腔内应用纤维蛋白溶解剂作为一种可能的治疗方法正在研究中。在此,我们报告4例因恶性胸腔积液住院的成年患者,他们在塞尔维亚共和国伏伊伏丁那肺病研究所接受了胸膜腔内纤维蛋白溶解疗法。